article · RMD Open

Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

George Karpouzas
Sarah R. Ormseth
Ellen‐Margrethe Hauge
Petros P. Sfikakis
Hani El‐Gabalawy
Patrick H Dessein
Miguel Á. González‐Gay
Carol Hitchon
I. J. Colunga-Pedraza
J. R. Azpiri-López
Alfonso Corrales
Durga Prasanna Misra
Anne Grete Semb
Linda Tsang
Solbritt Rantapää‐Dahlqvist
Virginia Pascual‐Ramos
Irazú Contreras-Yáñez
D. Á. Galarza-Delgado
Piet Leonardus Cornelis Maria van Riel
George D. Kitas

202410 citationsOpen accessUniversity of the Witwatersrand

Abstract

RA activity and inflammatory markers associated with risk of MACE in bDMARD non-users but not users suggesting the possibility of biological-specific benefits locally on arterial wall independently of effects on systemic inflammation.

Research topics

Rheumatoid Arthritis Research and Therapies
Systemic Lupus Erythematosus Research
Cytokine Signaling Pathways and Interactions

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1136/rmdopen-2024-004546

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.